GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Asiatic Laboratories Ltd (DHA:ASIATICLAB) » Definitions » Capex-to-Operating-Cash-Flow

Asiatic Laboratories (DHA:ASIATICLAB) Capex-to-Operating-Cash-Flow : 0.00 (As of . 20)


View and export this data going back to 2024. Start your Free Trial

What is Asiatic Laboratories Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

Asiatic Laboratories's Capital Expenditure for the six months ended in . 20 was BDT0.00 Mil. Its Cash Flow from Operations for the six months ended in . 20 was BDT0.00 Mil.

GuruFocus do not calculate Capex-to-Operating-Cash-Flow if the Cash Flow from Operations is negative.


Asiatic Laboratories Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for Asiatic Laboratories's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asiatic Laboratories Capex-to-Operating-Cash-Flow Chart

Asiatic Laboratories Annual Data
Trend
Capex-to-Operating-Cash-Flow

Asiatic Laboratories Semi-Annual Data
Capex-to-Operating-Cash-Flow

Competitive Comparison of Asiatic Laboratories's Capex-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Asiatic Laboratories's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asiatic Laboratories's Capex-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Asiatic Laboratories's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Asiatic Laboratories's Capex-to-Operating-Cash-Flow falls into.



Asiatic Laboratories Capex-to-Operating-Cash-Flow Calculation

Asiatic Laboratories's Capex-to-Operating-Cash-Flow for the fiscal year that ended in . 20 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- () /
=N/A

Asiatic Laboratories's Capex-to-Operating-Cash-Flow for the quarter that ended in . 20 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- () /
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Asiatic Laboratories  (DHA:ASIATICLAB) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


Asiatic Laboratories Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Asiatic Laboratories's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Asiatic Laboratories (DHA:ASIATICLAB) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Siddeshwari Circular Road, 42-43, Treasure Island (5 th Floor) Shantinagar, Dhaka, BGD, 1217
Asiatic Laboratories Ltd is engaged in manufacturing and marketing of a wide range of the rapeutical medicines pharmaceutical products in the categories of Biological, Non-Biological & Sterile Pharmaceutical dosage. It has 80 generic molecules comprising therapeutic classes like antibiotics, antihistamines, bronchodilators, vitamins-minerals, antiulcerants, laxatives, gastroprokinetics, antihematinic, anthelmentics, CNS drugs, respiratory drugs, NSAIDs, dermatological preparations and sterile ophthalmic preparations.

Asiatic Laboratories (DHA:ASIATICLAB) Headlines

No Headlines